Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €190 | ― | 32.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €36.5→€35 | ― | 3.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €24.8 | ― | 0.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €62→€60 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €4.8→€4.4 | ― | 3.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €123→€125 | ― | 12.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €25→€27 | ― | 13.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €15 | ― | 9.60% | Reiterated | ||||
Alstom SA | BUY €21.8→€24.8 | ― | -10.10% | Reiterated | J.P. Morgan Keeps Their Buy Rating on Alstom SA (0J2R) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €16→€18 | ― | 8.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €147 | ― | 9.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €6.7 | ― | 14.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €13.5→€11.5 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €9.5→€8.5 | ― | 0.80% | Reiterated | ||||
Alstom SA | HOLD €17 | ― | -9.50% | Reiterated | Bernstein Keeps Their Hold Rating on Alstom SA (0J2R) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €12→€11.5 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €129 | ― | 3.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €125→€128 | ― | 13.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €138 | ― | 1.10% | Reiterated | ||||
Compagnie de Saint Gobain | BUY €99 | ― | -2.10% | Reiterated | Goldman Sachs Remains a Buy on Compagnie de Saint Gobain (COD) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €91 | ― | 8.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €19 | ― | 7.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €21→€22 | ― | 8.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €132 | ― | 8.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €27 | ― | 10.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €95 | ― | 5.20% | Reiterated | ||||
Institut de Developpement Industriel SA IDI | HOLD €75 | ― | -4.80% | Reiterated | Institut de Developpement Industriel SA IDI (0I0P) Receives a Hold from Kepler Capital | ||||
Teleperformance | BUY €130 | ― | -4.80% | Reiterated | Kepler Capital Sticks to Their Buy Rating for Teleperformance (0J6X) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €67 | ― | 5.30% | Reiterated | ||||
Dassault Systemes | BUY €45 | ― | -7.70% | Reiterated | Kepler Capital Sticks to Its Buy Rating for Dassault Systemes (0HB4) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €25 | ― | 6.40% | Reiterated | ||||
Assystem | BUY €53 | ― | -0.10% | Reiterated | Assystem (0OA7) Gets a Buy from Kepler Capital | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €129.5 | ― | 11.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €2.5→€2 | ― | 11.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €180 | ― | 9.60% | Reiterated | ||||
STMicroelectronics NV | BUY €38 | ― | -6.20% | Reiterated | New Buy Rating for STMicroelectronics NV (0INB), the Technology Giant | ||||
Valneva | BUY €8.1 | ― | -11.90% | Reiterated | Kepler Capital Remains a Buy on Valneva (0OB3) | ||||
Genfit | BUY €8.4 | ― | -11.90% | Reiterated | Kepler Capital Keeps Their Buy Rating on Genfit (GNFTF) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €18.5 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €144 | ― | 8.70% | Reiterated | ||||
Air Liquide | BUY €151→€190 | ― | -3.30% | Upgraded | Positive Report for Air Liquide (0NWF) from Jefferies | ||||
JCDecaux SA | BUY €28.3→€24.4 | ― | -17.20% | Reiterated | Goldman Sachs Sticks to Its Buy Rating for JCDecaux SA (0MGO) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €10 | ― | 6.20% | Reiterated | ||||
STMicroelectronics NV | BUY €29 | ― | -6.30% | Reiterated | STMicroelectronics: Anticipated Growth Driven by Technological Advancements and Strategic Initiatives | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €84.5 | ― | 21.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €32 | ― | 17.30% | Reiterated | ||||
Axway Software | BUY €20.4→€33 | ― | -0.10% | Reiterated | Kepler Capital Reaffirms Their Buy Rating on Axway Software (0P5L) | ||||
GenSight Biologics SA | HOLD €0.4 | ― | -11.90% | Reiterated | Kepler Capital Reaffirms Their Hold Rating on GenSight Biologics SA (G49N) | ||||
Innate Pharma SA | HOLD €3.1 | ― | -11.90% | Reiterated | Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), Innate Pharma SA (Other OTC: IPHYF) and scPharmaceuticals (NASDAQ: SCPH) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €144 | ― | 14.20% | Reiterated |